Journal of Medicinal Chemistry, volume 31, issue 2, pages 362-366

6-[18F]fluorometaraminol: a radiotracer for in vivo mapping of adrenergic nerves of the heart.

Publication typeJournal Article
Publication date1988-02-01
scimago Q1
SJR1.986
CiteScore12.8
Impact factor6.8
ISSN00222623, 15204804
PubMed ID:  3339607
Drug Discovery
Molecular Medicine
Abstract
The false neurotransmitter metaraminol has been 18F labeled and evaluated as a possible heart imaging agent on the basis of its selective accumulation in adrenergic nerves. Reaction of 6-(acetoxymercurio)-N-t-BOC-metaraminol with acetyl hypofluorite followed by removal of the BOC group provides a regiospecific synthesis of 6-fluorometaraminol (4). Use of acetyl hypo[18F]fluorite gives [18F]-4 in 60 min in 20-42% radiochemical yield. Systemic blockade of the neuronal uptake-1 carrier with desmethylimipramine or systemic destruction of the adrenergic nerves with 6-hydroxydopamine lowers [18F]-4 accumulation greater than or equal to 85% in all four regions of the rat heart. These preliminary findings suggest that [18F]-4 could be used to assess neuronal damage in various heart diseases by positron emission tomography.

Top-30

Journals

1
2
3
4
5
6
7
8
1
2
3
4
5
6
7
8

Publishers

2
4
6
8
10
12
14
16
18
2
4
6
8
10
12
14
16
18
  • We do not take into account publications without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Share
Cite this
GOST | RIS | BibTex | MLA
Found error?